Safety, Efficacy, and Feasibility of Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia: A Randomized Clinical Trial

IMPORTANCE: Insulin modulates aspects of brain function relevant to Alzheimer disease and can be delivered to the brain using intranasal devices. To date, the use of intranasal insulin to treat persons with mild cognitive impairment and Alzheimer’s disease dementia remains to be examined in a multi-...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:JAMA Neurol
Glavni autori: Craft, Suzanne, Raman, Rema, Chow, Tiffany W., Rafii, Michael S., Sun, Chung-Kai, Rissman, Robert A., Donohue, Michael C., Brewer, James B., Jenkins, Cecily, Harless, Kelly, Gessert, Devon, Aisen, Paul S.
Format: Artigo
Jezik:Inglês
Izdano: American Medical Association 2020
Teme:
Original Investigation
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7309571/
https://ncbi.nlm.nih.gov/pubmed/32568367
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaneurol.2020.1840
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items